Takeda Pharmaceutical Company Limited
Utility Patents
Last updated:
List of all Takeda Pharmaceutical Company Limited patents 138 in total
| Status | Patent |
|---|---|
Grant | Utility: Heterocyclic compounds Filling date: 8 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Heterocyclic compound and use thereof Filling date: 8 Sep 2025 Issue date: 13 Sep 2022 |
Grant | Utility: Anti-CD38 antibodies Filling date: 8 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Formulation of an antibody and use thereof Filling date: 8 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6 Filling date: 8 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Virus filtration of cell culture media Filling date: 8 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Constrained conditionally activated binding proteins Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Methods for purification of arysulfatase A Filling date: 8 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Nucleic acids encoding plasma kallikrein binding proteins Filling date: 8 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Anti-MIF immunohistochemistry Filling date: 8 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Fused heterocyclic compound Filling date: 8 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Bispecific antibodies against plasma kallikrein and Factor XII Filling date: 8 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Heteroaryl plasma kallikrein inhibitors Filling date: 8 Sep 2025 Issue date: 28 Jun 2022 |
Grant | Utility: Assays for determining plasma kallikrein system biomarkers Filling date: 8 Sep 2025 Issue date: 28 Jun 2022 |
Grant | Utility: Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase Filling date: 8 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Inhibitors of plasma kallikrein and uses thereof Filling date: 8 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Prevention and reduction of blood loss Filling date: 8 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: Metabolite biomarkers for diseases associated with the contact activation system Filling date: 8 Sep 2025 Issue date: 24 May 2022 |
Grant | Utility: Heterocyclic compound and application thereof Filling date: 8 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Syringe Filling date: 8 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Anti-plasma kallikrein antibodies Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Purification of factor VIII subspecies Filling date: 8 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Substituted piperidine compound and use thereof Filling date: 8 Sep 2025 Issue date: 5 Apr 2022 |
Grant | Utility: Treatment of CNS conditions Filling date: 8 Sep 2025 Issue date: 29 Mar 2022 |
Grant | Utility: Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack Filling date: 8 Sep 2025 Issue date: 29 Mar 2022 |
Grant | Utility: Heterocyclic compound and use thereof Filling date: 8 Sep 2025 Issue date: 22 Mar 2022 |
Grant | Utility: Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease Filling date: 8 Sep 2025 Issue date: 15 Mar 2022 |
Grant | Utility: Heterocyclic compound Filling date: 8 Sep 2025 Issue date: 15 Mar 2022 |
Grant | Utility: ADAMTS13 protein cell culture supernatant Filling date: 8 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A Filling date: 8 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use Filling date: 8 Sep 2025 Issue date: 8 Feb 2022 |
Grant | Utility: Heterocyclic compound Filling date: 8 Sep 2025 Issue date: 8 Feb 2022 |
Grant | Utility: Heterocyclic compound Filling date: 8 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Heterocyclic compound Filling date: 8 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Heterocyclic compound Filling date: 8 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Syringe Filling date: 8 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Pooling device for single or multiple medical containers Filling date: 8 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Lyophilized recombinant VWF formulations Filling date: 8 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome Filling date: 8 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Recombinant VWF formulations Filling date: 8 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Subcutaneous administration of ADAMTS13 Filling date: 8 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Aromatic compound Filling date: 8 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Substrate clearance assays for lysosomal enzymes Filling date: 8 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Filling date: 8 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: 4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139 Filling date: 8 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Peptide compound Filling date: 8 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Prophylactic or therapeutic agent for delirium Filling date: 8 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Inhibitors of Plasma Kallikrein and uses thereof Filling date: 8 Sep 2025 Issue date: 9 Nov 2021 |
Grant | Utility: Method of predicting effects of CDC7 inhibitor Filling date: 8 Sep 2025 Issue date: 26 Oct 2021 |
Showing 1 to 50 of 138 patents.